cbdMD Inc. (YCBD) News

cbdMD Inc. (YCBD): $1.69

-0.20 (-10.58%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add YCBD to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

NR

Ranked

#157 of 177

in industry

Filter YCBD News Items

YCBD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

YCBD News Highlights

  • For YCBD, its 30 day story count is now at 2.
  • Over the past 5 days, the trend for YCBD's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about YCBD are CBD and SG.

Latest YCBD News From Around the Web

Below are the latest news stories about CBDMD INC that investors may wish to consider to help them evaluate YCBD as an investment opportunity.

cbdMD Stabilizes Revenue and Significantly Improves Operating Results

Company reduces annualized SG and A expenses $24 million year over year Charlotte, North Carolina--(Newsfile Corp. - May 15, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator the leading CBD brands - including its flagship brand cbdMD, and its animal health brand Paw CBD, today announced our second quarter of fiscal 2023 results. For the second quarter of ...

Yahoo | May 15, 2023

cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2023 Results

Charlotte, North Carolina--(Newsfile Corp. - May 10, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:15 p.m., Eastern Time, on Monday, May 15, 2023, to discuss the company's March 31, 2023 second quarter of fiscal 2023 financial results and business progress.CONFERENCE CALL DETAILSMonday, May 15, 2023, 4:15 p.m. Eastern TimeUSA/Canada:800-319

Yahoo | May 10, 2023

cbdMD Announces Closing of $2.8 Million Underwritten Public Offering of Common Stock

Charlotte, North Carolina--(Newsfile Corp. - May 3, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading CBD companies, today announced the closing of its previously announced underwritten public offering of 1,350,000 shares of its common stock at a public offering price of $2.10 per share. Gross proceeds from the offering before deducting underwriting discounts and commissions and offering expenses were approximately $2.8 million. Maxim Group LLC acted

Yahoo | May 3, 2023

cbdMD Announces Pricing of $2.8 Million Underwritten Public Offering of Common Stock

Charlotte, North Carolina--(Newsfile Corp. - April 30, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading CBD companies, today announced the pricing of its previously announced underwritten public offering of 1,350,000 shares of its common stock at a public offering price of $2.10 per share. Gross proceeds from the offering are expected to be approximately $2.8 million before deducting underwriting discounts, commissions, and estimated offering expens

Yahoo | May 1, 2023

cbdMD Announces Proposed Public Offering of Common Stock

Charlotte, North Carolina--(Newsfile Corp. - April 28, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading CBD companies, today announced it has commenced an underwritten public offering of shares of its common stock. All shares of common stock in the offering are to be sold by cbdMD. In addition, cbdMD intends to grant the underwriter in the offering a 45-day option to purchase up to an additional 15% ...

Yahoo | April 28, 2023

cbdMD's Clinical Study Supports Improved Mobility in Dogs

Results from the canine clinical study suggest that cbdMD's proprietary blend promotes mobility in dogs Charlotte, North Carolina--(Newsfile Corp. - April 18, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the results from its canine clinical study conducted at Colorado State University. The clinical study explored the benefits of our core broad spectrum hemp extract in dogs, and

Yahoo | April 18, 2023

cbdMD, Inc. Announces One-for-Forty Five Reverse Stock Split of Its Common Stock

Charlotte, North Carolina--(Newsfile Corp. - April 14, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leading provider of high-quality CBD products, announced today that its board of directors on April 12, 2023 approved a ratio of one-for-forty five reverse stock split of the Company's issued and outstanding shares of common stock. The Company's shareholders previously approved the reverse stock split on February 16, 2023 and granted the board the authority to determine ...

Yahoo | April 14, 2023

cbdMD Expands its Reach to The United Kingdom with Launch on Amazon UK

cbdMD Enters the UK Market with Debut on Amazon UK, Offering High-Quality CBD Solutions for Wellness and Self-Care Charlotte, North Carolina--(Newsfile Corp. - April 12, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, announces the successful launch of its Novel Food validated premium hemp-derived CBD products on Amazon.co.uk in the United Kingdom ("Amazon UK"). cbdMD gummies, tinctures, and topic

Yahoo | April 12, 2023

cbdMD™ Makes History Becoming the First CBD Brand to Achieve 3 NSF’s Certified for Sport® Certifications

CHARLOTTE, N.C., March 07, 2023--New suite of products allows professionals from all walks of life to add CBD to their regimen without fear of failing a drug test for THC.

Yahoo | March 7, 2023

cbdMD to Present at NutraIngredients-USA's Sports and Active Nutrition Summit

Charlotte, North Carolina--(Newsfile Corp. - February 16, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted, and widely recognized CBD companies, announces its General Counsel, Lance Blundell, and Chief Science Officer, Dr. Sibyl Swift, will be speaking on a panel at the Sports and Active Nutrition Summit, USA - Sponsored by Nutraingredients. The executives will discuss the benefits of CBD in sports nutrition, including the Company's .

Yahoo | February 16, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7185 seconds.